Methotrexate Early Toxicity Monitoring
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to Primary Central Nervous System Lymphoma
Related studies linked through entity extraction aliases.
A Multicenter Two-Cohort Study of Methotrexate, Rituximab, Sintilimab and Pirtobrutinib for Treatment-Naive PCNSL vs. Real-World Investigator-Selected Treatment (Observational Cohort)
- Status
- RECRUITING
- Phase
- PHASE2
Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)
- Status
- RECRUITING
- Phase
- PHASE1
Tirabrutinib Maintenance Versus Placebo in Patients With Primary CNS Lymphoma in Complete Remission (JCOG2104)
- Status
- RECRUITING
- Phase
- PHASE2
Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCL
- Status
- RECRUITING
- Phase
- NA
Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNSL Patients
- Status
- RECRUITING
- Phase
- PHASE3
Q702 for the Treatment of Patients With Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Phase I Study Evaluating Tolerability, Safety, Pharmacokinetics, and Efficacy of Combined ONO-4059 and R-MPV Therapy for PCNSL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL
- Status
- RECRUITING
- Phase
- PHASE1
First-line Treatment of PCNSL With the Combination of Orelabrutinib, Rituximab, and Methotrexate (ORM Regimen)
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Study Evaluating the Safety and Efficacy of ZRMT Regimen in the Treatment of PCNSL
- Status
- RECRUITING
- Phase
- NA
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
- Status
- RECRUITING
- Phase
- PHASE2
New-diagnosed PCNSL Treated With Methotrexate (MTX) and Orelabrutinib-based Regimen
- Status
- COMPLETED
- Phase
- N/A
Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas
- Status
- RECRUITING
- Phase
- PHASE2
Orelabrutinib,Rituximab and Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Orelabrutinib,Rituximab and Methotrexate in Newly-diagnosed Primary Central Nervous System Lymphoma(PCNSL)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of GNC-038, a Tetra-specific Antibody, in Patients With Central Nervous System Lymphoma (PCNSL) and Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
[18F]-Fludarabine PET/MRI in Primary Central Nervous System Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1